远端 他的捆节奏在一个病人手术纠正复杂的埃布斯坦异常和症状的二度心房阻塞:一个病例报告
Ivelin Koev1,2, G Andre Ng1,2,3, Aidan P Bolger1,3,4
1Department of Cardiovascular Sciences, University of Leicester, University Rd, Leicester LE1 7RH, UK.
European heart journal. Case reports
|December 4, 2023
概括
这项研究为患有心脏阻塞的埃布斯坦异常患者提供了一种新的治疗方法,使用导电系统节奏 (CSP). 在一个年轻的患者中,HIS捆绑节奏成功地纠正了Mobitz II心房 (AV) 阻塞和右捆枝阻塞 (RBBB).
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 遗传性心脏病是一种先天性心脏病.
背景情况:
- 埃布斯坦异常是一种先天性心脏缺陷,其特征是三管的顶部位移.
- 它通常与其他心脏疾病有关,包括心律失常和导电系统疾病.
- 二级莫比茨II心房 (AV) 阻塞是一种罕见但严重的并发症.
研究的目的:
- 介绍一个成功导电系统节奏 (CSP) 的新案例,该病例发生在患有埃布斯坦异常和莫比茨II AV阻塞的患者身上.
- 突出HIS捆绑节奏在复杂的先天性心脏病中的可行性和益处.
- 在需要长期支持的年轻患者中展示传统节奏的替代方案.
主要方法:
- 一名42岁的女性患有复杂的先天性心脏病,包括埃布斯坦异常,接受了CSP.
- 远程HIS捆绑节奏使用可偏向的HIS导管和Selectsecure 3830进行.
- 该程序旨在纠正症状的Mobitz II AV阻塞和先前存在的右捆分支阻塞.
主要成果:
- 成功植入了一个HIS捆绑节奏系统.
- 纠正第二级Mobitz II AV阻塞和右束分支阻塞.
- 患者没有出现急性并发症,第二天就出院了.
结论:
- 远端HIS节奏是手术治疗埃布斯坦异常患者心脏阻塞的可行和有效治疗方法.
- 这种节奏策略可以使QRS复合体正常化,并可能保护或改善左心室功能.
- CSP为年轻患有需要节奏的先天性心脏病的患者提供了一个有前途的替代方案.
相关概念视频
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
21
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
21
01:28Disturbances in Heart Rhythm
972
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
972
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
845
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
845
01:28Mechanism of Cardiac Arrhythmias
925
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
925
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
747
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
747